Get the Stockscreener App
2.63
6.07%
-0.17
Ventyx Biosciences Inc stock is traded at $2.63, with a volume of 545.13K.
It is down -6.07% in the last 24 hours and up +27.36% over the past month.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
See More
Previous Close:
$2.80
Open:
$2.75
24h Volume:
545.13K
Relative Volume:
0.34
Market Cap:
$187.15M
Revenue:
-
Net Income/Loss:
$-192.96M
P/E Ratio:
-0.797
EPS:
-3.3
Net Cash Flow:
$-167.04M
1W Performance:
-17.30%
1M Performance:
+27.36%
6M Performance:
+30.85%
1Y Performance:
+17.41%
1-Day Range:
$2.615
$2.78
1-Week Range:
$2.615
$3.19
52-Week Range:
$0.783
$3.39
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Name
Ventyx Biosciences Inc
Sector
Industry
Phone
(858) 945-2393
Address
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Compare VTYX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
2.63 | 199.25M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-12-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-07-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-07-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-07-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-07-23 | Downgrade | Stifel | Buy → Hold |
| Nov-07-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jun-14-23 | Resumed | Credit Suisse | Outperform |
| Mar-21-23 | Initiated | Wells Fargo | Overweight |
| Dec-19-22 | Initiated | Goldman | Buy |
| Nov-17-22 | Initiated | Morgan Stanley | Overweight |
| Sep-07-22 | Initiated | Stifel | Buy |
| Sep-01-22 | Initiated | H.C. Wainwright | Buy |
| May-09-22 | Initiated | Credit Suisse | Outperform |
| Mar-31-22 | Initiated | Canaccord Genuity | Buy |
| Feb-01-22 | Initiated | Oppenheimer | Outperform |
| Nov-15-21 | Initiated | Jefferies | Buy |
| Nov-15-21 | Initiated | Piper Sandler | Overweight |
View All
Ventyx Biosciences Inc Stock (VTYX) Latest News
Institutional scanner results for Ventyx Biosciences Inc.Buy and Hold Position Summary Review - Newser
Short Interest in Ventyx Biosciences, Inc. (NASDAQ:VTYX) Rises By 69,900.0% - Defense World
How to use Fibonacci retracement on Ventyx Biosciences Inc.Chart Risk Profile for Capital Preservation - Newser
What recovery options are there for Ventyx Biosciences Inc.Swing Trade Watchlist with Entry Zones - Newser
Applying sector rotation models to Ventyx Biosciences Inc.Free Growth Based Investment Plan Guidance - Newser
Real time social sentiment graph for Ventyx Biosciences Inc.Retirement Investment Outlook and Return Summary - Newser
What are analysts’ price targets for Ventyx Biosciences Inc. in the next 12 monthsReal Time Watchlist With Proven Results - jammulinksnews.com
Is Ventyx Biosciences Inc. forming a bottoming baseBuy Zone Strategy with Pattern Recognition - Newser
Is it time to cut losses on Ventyx Biosciences Inc.Yield Curve Outlook and Long-Term Implication Summary - Newser
Ventyx Biosciences Inc. Stock Support and Resistance Levels You Should KnowFree Trade Setups With Clear Risk Limits - Newser
Will Ventyx Biosciences Inc. rebound enough to break evenShort-Term Profit Alert With Entry Forecast - Newser
Ventyx Biosciences Inc. stock chart pattern explainedGrowth Watchlist for Long Term Positioning - Newser
Why Ventyx Biosciences Inc. stock attracts strong analyst attentionLow Volatility Stable Growth Picks Rank High - metal.it
Published on: 2025-07-30 05:04:48 - Newser
What candlestick patterns are forming on Ventyx Biosciences Inc.Weekly High Conviction Trade Setup Analysis - Newser
Full technical analysis of Ventyx Biosciences Inc. stockTechnical Setup Guide for Daily Watchlist - Newser
What makes Ventyx Biosciences Inc. stock price move sharplyGrowth Based Stock Signal Screener Updated - metal.it
Applying big data sentiment scoring on Ventyx Biosciences Inc.Free Safe Entry Stock Watch Suggestions - Newser
How Resilient Is Ventyx Biosciences Inc. Stock During Economic DownturnsDaily Technical Forecast for Quick Gains - Newser
Top Penny Stocks To Watch In July 2025 - simplywall.st
Ventyx Biosciences Inc. stock chart pattern explained High Confidence Strategy with Trend Alignment - Newser
Is it time to cut losses on Ventyx Biosciences Inc. Momentum Screener with Buy and Sell Areas - Newser
Will Ventyx Biosciences Inc. rebound enough to break even Weekly Price Target Forecast and Alerts - Newser
What is the risk reward ratio of investing in Ventyx Biosciences Inc. stockUnlock daily market insights for better trades - jammulinksnews.com
What is Ventyx Biosciences Inc. company’s growth strategyAchieve exceptional returns with expert guidance - jammulinksnews.com
What are the latest earnings results for Ventyx Biosciences Inc.High-impact investment strategies - jammulinksnews.com
Should I hold or sell Ventyx Biosciences Inc. stock in 2025Exceptional profit velocity - jammulinksnews.com
How volatile is Ventyx Biosciences Inc. stock compared to the marketCapitalize on fast-growing investment opportunities - jammulinksnews.com
Published on: 2025-07-27 20:10:21 - jammulinksnews.com
What analysts say about Ventyx Biosciences Inc. stockExceptional profit velocity - PrintWeekIndia
Ventyx Biosciences Inc. Stock Analysis and ForecastRapid market gains - PrintWeekIndia
Is Ventyx Biosciences Inc. a good long term investmentPowerful market insights - PrintWeekIndia
How Ventyx Biosciences Inc. stock performs during market volatilityPredictable Return Stock Picks - Newser
What drives Ventyx Biosciences Inc. stock priceTremendous growth opportunities - jammulinksnews.com
Ventyx Biosciences Inc Stock (VTYX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):